GLP - Testing Facility is defined as which of the following?

GLP - Testing Facility is defined as which of the following?

• A. Facility that conducts a nonclinical study and is required to register with the FDA
• B. A lab that only handles data analysis
• C. A facility that exclusively performs clinical trials
• D. An organization that writes regulatory guidelines

Answer: (A)

In GLP, the testing facility is the place where nonclinical safety studies are actually conducted under Good Laboratory Practice. It is tied to regulatory oversight, including registration with the FDA, to ensure the studies meet GLP standards, with proper facilities, trained personnel, documented procedures, and quality assurance. This registration helps ensure the data produced from nonclinical studies (such as toxicology or pharmacology studies) are reliable and can be submitted to regulators. That’s why the best choice describes a facility that conducts a nonclinical study and is required to register with the FDA. The other options don’t fit GLP: a lab that only analyzes data isn’t conducting the studies themselves; a facility that exclusively performs clinical trials operates in humans, which is outside the nonclinical GLP scope; and an organization that writes regulatory guidelines isn’t conducting GLP testing.

In GLP, the testing facility is the place where nonclinical safety studies are actually conducted under Good Laboratory Practice. It is tied to regulatory oversight, including registration with the FDA, to ensure the studies meet GLP standards, with proper facilities, trained personnel, documented procedures, and quality assurance. This registration helps ensure the data produced from nonclinical studies (such as toxicology or pharmacology studies) are reliable and can be submitted to regulators.

That’s why the best choice describes a facility that conducts a nonclinical study and is required to register with the FDA. The other options don’t fit GLP: a lab that only analyzes data isn’t conducting the studies themselves; a facility that exclusively performs clinical trials operates in humans, which is outside the nonclinical GLP scope; and an organization that writes regulatory guidelines isn’t conducting GLP testing.